Potomac, MD, United States of America

Jonathan Cohen

USPTO Granted Patents = 4 


Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Potomac, MD (US) (2004 - 2005)
  • Rockville, MD (US) (2023 - 2024)

Company Filing History:


Years Active: 2004-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jonathan Cohen in Cancer Prediction

Introduction

Jonathan Cohen is an accomplished inventor based in Potomac, MD, United States. With a remarkable portfolio of 4 patents, he is making significant strides in the field of medical technology, particularly in non-invasive methods for cancer prediction. His ground-breaking innovations harness machine learning systems, enhancing the accuracy of cancer risk assessment.

Latest Patents

Cohen's latest patents focus on methods and machine learning systems that predict the likelihood or risk of having cancer. The embodiment of his inventions emphasizes non-invasive tests that measure biomarkers, such as tumor antigens, while also collecting essential clinical parameters from patients. Utilizing computer-implemented machine learning methods, his patented systems assess the likelihood of a patient having a disease with respect to a patient population or cohort population. The invention describes a classifier generated based on training data and a subset of inputs, which includes at least two biomarkers and one clinical parameter, each having its associated weight. This classifier is designed to meet predetermined Receiver Operator Characteristic (ROC) statistic requirements, thereby specifying sensitivity and specificity crucial for the correct classification of patients. Ultimately, this classifier aids in categorizing patients into likelihood categories for having cancer or not, enhancing early detection and intervention strategies.

Career Highlights

Jonathan Cohen has been pivotal in the advancements at Genesystems Inc., where he has been working since 2020. His work has contributed immensely to improving methodologies that can revolutionize cancer detection processes, making a potential difference in countless lives. His innovative thinking and dedication to medical advancements reflect a strong commitment to the field of healthcare technology.

Collaborations

Throughout his career, Cohen has collaborated with notable colleagues, including Vladimir Knezevic and Dan-Paul Hartmann. These partnerships with talented individuals in the industry not only reflect his collaborative spirit but also signify a collective effort to push the boundaries of medical technology and cancer research forward.

Conclusion

Jonathan Cohen's inventions and developments in predicting cancer risks highlight the transformative role of innovation in healthcare. With his continuing efforts and collaboration with his peers, he is poised to make substantial contributions to the early detection and treatment of cancer, ultimately improving patient outcomes and fostering a healthier future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…